TCI-HeartMate I (IP/VE)
Author:
Wilhelm M. J.,Rötger J.
Reference24 articles.
1. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, Rose EA, Oz M, Itescu S (1999) Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 100 (Suppl): II211–II215 2. Bonkohara Y, Minami K, Arusoglu L, El-Banayosy A, Fey O, Sarnowski P, Körfer R (1999) A fatal mechanical disorder of the TCI HeartMate left ventricular assist system. J Thorac Cardiovasc Surg 118: 769–770 3. Deng MC, Breithardt G, Scheld HH (1999) Towards an evidence based perspective in advanced heart failure care. Z Kardiol 88 (Suppl 3): III/1-III/4 4. Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH (2000) Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 321 (7260): 540–545 5. DeRose JJ Jr, Umana JP, Argenziano M, Catanese KA, Gardocki MT, Flannery M, Levin HR, Sun BC, Rose EA, Oz MC (1997) Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 30: 1773–1777
|
|